CTOs on the Move

Lee Pharmaceuticals

www.leepharmaceuticals.com

 
Lee Pharmaceuticals is an established manufacturer of quality lip balm, saline nasal spray and OTC products. We are aggressively pursuing the Private Label Lip Balm and OTC business with our products that are national brand equivalent.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Allegiance Life

Allegiance Life is a Missoula, MT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HASTINGS and PRINCE ED CNTY HLTH

HASTINGS and PRINCE ED CNTY HLTH is a Belleville, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Grane Rx

Grane Rx is a leader in long term care pharmacy solutions and services, supporting long term care communities and PACE providers. Grane Rx offers LTC pharmacy solutions and PACE pharmacy solutions for Pennsylvania, North Carolina, Massachusetts, New Je...

Tocagen

Tocagen is a clinical stage, biopharmaceutical company pursuing the discovery, development and commercialization of gene therapy products for the treatment of cancer.

Synthetic Biologics

Synthetic Biologics, Inc. trades on the NYSE MKT, LLC under the symbol "SYN". The Company`s principal executive offices are located in Rockville, MD, and the finance and administrative office is located in Ann Arbor, MI. Synthetic Biologics, Inc. is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Company`s lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection and antibiotic-associated diarrhea (AAD), and SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat the underlying cause of irritable bowel syndrome with constipation (IBS-C). In addition, the Company is developing a monoclonal antibody combination for the treatment of Pertussis, and a Phase 2 oral estriol drug for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS.